Literature DB >> 15151550

Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study.

Ozcan Bor1, Ener Cagri Dinleyici, Mahmut Kebapci, Sultan Durmus Aydogdu.   

Abstract

BACKGROUND: Cholelithiasis is a rare condition seen during childhood. The aim of this study was to determine frequency of biliary sludge and cholelithiasis with ceftriaxone therapy.
METHODS: Thirty-eight children aged between 1 month and 17 years were evaluated with ultrasonographic examination at the initiation of the ceftriaxone therapy and 10th day of therapy, consecutively. If biliary sludge or cholelithiasis were demonstrated, scans were repeated monthly until pathology disappeared.
RESULTS: Abnormal gallbladder sonograms were demonstrated in 36.8% (n = 14) of patients at the 10th day of therapy. Cholelithiasis was detected in 28.9% (n = 11) of patients and biliary sludge was detected in 7.9% (n = 3). Two children still had cholelithiasis at the 30th day after therapy and one had cholelithiasis after the 60th day. The 9-year-old girl who still had cholelithiasis after 60 days of therapy also had nausea, vomiting and abdominal pain at 7 days after cessation of therapy. Her 90th day sonographic examination was normal.
CONCLUSION: Reversible biliary sludge or pseudocholelithiasis due to ceftriaxone treatment is not a rare condition. Therefore it is benign, spontaneously resolved and clinical signs are usually absent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151550     DOI: 10.1111/j.1328-0867.2004.01884.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  13 in total

1.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

2.  The polymicrobial Actinomyces naeslundii and Pseudomonas aeruginosa sepsis in a patient with ulcerative colitis 2 months after colonoscopy.

Authors:  Mirjana Balen Topić; Boško Desnica; Ninoslava Vicković; Tomislava Skuhala; Kristijan Bayer; Suzana Bukovski
Journal:  Wien Klin Wochenschr       Date:  2013-12-03       Impact factor: 1.704

3.  A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.

Authors:  Naoki Kutuya; Yutaka Ozaki; Tadaharu Okazaki
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

4.  Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.

Authors:  Takahisa Kimata; Kazunari Kaneko; Masaya Takahashi; Masato Hirabayashi; Tomohiko Shimo; Minoru Kino
Journal:  Pediatr Nephrol       Date:  2011-10-27       Impact factor: 3.714

5.  Ceftriaxone associated urolithiasis in a child with hypercalciuria.

Authors:  V J Lozanovski; Z Gucev; V J Avramoski; I Kirovski; P Makreski; V Tasic
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

6.  Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.

Authors:  Alper Otunctemur; Emin Ozbek; Emre Can Polat; Mustafa Cekmen; Murat Dursun; Suleyman Sami Cakir
Journal:  Urolithiasis       Date:  2013-12-06       Impact factor: 3.436

7.  Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.

Authors:  Hanna Alemayehu; Amita A Desai; Priscilla Thomas; Susan W Sharp; Shawn D St Peter
Journal:  Pediatr Surg Int       Date:  2014-01-28       Impact factor: 1.827

8.  Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.

Authors:  Aya Imafuku; Naoki Sawa; Akinari Sekine; Masahiro Kawada; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Noriko Hayami; Jyunichi Hoshino; Yoshifumi Ubara; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2017-10-12       Impact factor: 2.801

9.  Urinary sludge caused by ceftriaxone in a young boy.

Authors:  Takahisa Kimata; Kazunari Kaneko; Masaya Takahashi; Sohsaku Yamanouchi; Shoji Tsuji; Minoru Kino
Journal:  Pediatr Rep       Date:  2012-03-26

10.  Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone.

Authors:  Elena Ratti; James D Berry; David J Greenblatt; Lorena Loci; Amy Swartz Ellrodt; Jeremy M Shefner; Merit E Cudkowicz
Journal:  Toxicol Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.